跳至主要内容
临床试验/JPRN-UMIN000029921
JPRN-UMIN000029921已完成未知

Study of effects on the retina and the choroid of intravitreal ranibizmab injection in patients with macular edema due to central retinal vein occlusion. - Study of effects of Ranibizmab in patients with macular edema due to central retinal vein occlusion.

agasaki University Hospital0 个研究点目标入组 30 人开始时间: 2017年11月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients who underwent the pan-retinal photocoagulation within 3 months. 2.Patients who underwent photocoagulation treatment for macular edema within 3 months. 3.Patients treated with steroids to intraocular within 3 months. 4.Patients who underwent anti-VEGF injection for macular edema within 3 months. 3.Patients treated with steroids to intraocular within 3 months. 5.The patients with a history of hypersensitivity to the study drug. 6.Patients who developed heart and cerebrovascular disease severe within 6 months. 7.Patients attending physician was deemed inappropriate as a subject.

研究者

发起方
agasaki University Hospital

相似试验